In addition, TAMs have been implicated in the restriction of T cells in the micro-environment [80] and blocking TAMs recruitment in breast cancer mouse models can increase CD8+ T cell infiltration and their cytotoxic activity in the primary tumor [81,82]. The gene discussed is CD8A; the disease is breast carcinoma.